Hyperlipidemia
Episodes 1-16 of 26
- CME/CE Broadcast Replay
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
0.50 credits
Prof. Ulrich Laufs
Pam R. Taub, MD, FACC, FASPC
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Christie Ballantyne, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Prof. Kausik Ray
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
- MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
1.00 program creditBørge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne, MD
P. Gabriel Steg, MD
Pam R. Taub, MD, FACC, FASPC
Erik Stroes
- Prev
- Next